Megan Brooks

1 day ago | medscape.com | Megan Brooks

Advanced practice providers (APPs) can be trained to perform transnasal endoscopy (TNE) with a single-use ultra-slim gastroscope with only topical anesthesia, a pilot study showed. “Our study showed that TNE can be performed safely by APPs, is well tolerated by patients, and significantly impacted patient management,” Whitney Kucher, PA-C, with Northwestern Medicine, Chicago, told Medscape Medical News.

1 day ago | medscape.com | Megan Brooks

A dedicated onconephrology service at Brigham and Women’s Hospital (BWH), Boston, improved acute kidney injury (AKI) recovery rates in patients treated for cancer, according to a preliminary before-and-after analysis. Onconephrology is an emerging subspecialty focused on managing kidney complications in patients with cancer. These complications may stem from the cancer itself or from treatments such as chemotherapy, immunotherapy, or stem cell transplantation.

2 days ago | medscape.com | Megan Brooks

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation decisions, a real-world study showed. A retrospective analysis of charts of more than 350 patients with MS revealed that integrating multi-analyte biomarker data from the Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) Test changed clinical practice in nearly 20% of cases.

2 days ago | medscape.com | Megan Brooks

The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of acute migraine to alleviating common prodromal symptoms of migraine, according to an exploratory analysis from the phase 3 PRODROME trial.

2 days ago | portugues.medscape.com | Megan Brooks

Os dados de vigilância mais recentes dos Centers for Disease Control and Prevention (CDC) dos Estados Unidos mostram um aumento acentuado na prevalência do transtorno do espectro autista (TEA), dando continuidade a uma tendência de crescimento nos diagnósticos. Embora a maior de conscientização e o avanço nos critérios de diagnóstico provavelmente tenham contribuído para esse aumento, ainda há dúvidas sobre quais outros fatores estariam impulsionando esse fenômeno.